Chinnery, PF, Di Mauro, S, Shanske, S, et al. Risk of developing a mitochondrial DNA deletion disorder. Lancet 2004; 364: 592–6.Google Scholar

Callaway, JL, Shaffer, LG, Chitty, LS, et al. The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenal Diagn 2013; 33: 1119–23.Google ScholarPubMed

Wapner, RJ, Martin, CL, Levy, B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012; 367: 2175–84.CrossRefGoogle ScholarPubMed

Committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis. American College of Obstetricians and Gynecologists Committee on Genetics. Obstet Gynecol 2013; 122: 1374–7.Google Scholar

Royal College of Physicians, Royal College of Pathologists and British Society for Human Genetics. Consent and confidentiality in clinical genetic practice: guidance on genetic testing and sharing genetic information, 2^nd edn. Report of the Joint Committee on Medical Genetics. London: RCP, RCPath, 2011. www.bsgm.org.uk (accessed January 30, 2014).Google Scholar

Finning, K, Martin, P, Summers, J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 336: 816–8.CrossRefGoogle ScholarPubMed

Hill, M, Finning, K, Martin, P, et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2011; 80(1): 68–75.CrossRefGoogle ScholarPubMed

Firth, H, Hurst, J. Oxford Desk Reference – Clinical Genetics. Oxford, UK: Oxford University Press, 2005.Google Scholar

Strachan, T, Read, A. Human Molecular Genetics 4th edn. Garland Science, Taylor & Francis Group, LLC, 2011.Google Scholar

Gardner, RJM, Sutherland, GR, Shaffer, LG. Chromosome Abnormalities and Genetic Counselling, 4th edn. Oxford, UK: Oxford University Press, 2012.Google Scholar